hit counter
Chembio Diagnostics, Inc. (CEMI) Stock News Sentiment & Price - Sentifly
CEMI - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Chembio Diagnostics, Inc. (CEMI)

USA
Diagnostic Substances
NASDAQ
CEMI Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CEMI Latest news
GlobeNewsWire
Neutral
Chembio Announces EUA Submission for DPP Respiratory Antigen Panel
2021-09-22 08:00

Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2 Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2

PennyStocks
Neutral
Investing in Penny Stocks in September? 3 Strategies to Know
2021-08-29 18:15

Trading penny stocks in September? You need to know these 3 things The post Investing in Penny Stocks in September?

PennyStocks
Positive
Hot Penny Stocks to Buy This Month? 3 to Watch Now
2021-08-29 11:30

Which penny stocks are on your watchlist for next month? The post Hot Penny Stocks to Buy This Month?

Benzinga
Positive
Why Chembio Diagnostics Shares Are Trading Higher Today
2021-08-27 15:43

Chembio Diagnostics Inc (NASDAQ: CEMI) is trading higher Friday after the company announced its launch of commercial distribution of SCOV-2 Ag Detect Rapid Test, a third party COVID-19 antigen assay. Chembio Diagnostics said product inventory is on-hand and immediately available for shipment to customers across the United States.

Benzinga
Positive
Chembio Starts Distribution of Third-Party COVID-19 Antigen Assay
2021-08-27 08:34

Chembio Diagnostics Inc (NASDAQ: CEMI) has launched the commercial distribution of an FDA-Emergency Use Authorized rapid point-of-care COVID-19 antigen test.  Product inventory is on-hand and immediately available for shipment to Chembio customers across the U.S.

GlobeNewsWire
Neutral
Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay
2021-08-27 08:00

HAUPPAUGE, N.Y., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its launch of commercial distribution of an FDA Emergency Use Authorized, patent pending, rapid point-of-care COVID-19 antigen test for use in decentralized and traditional testing settings. Product inventory is on-hand and immediately available for shipment to Chembio customers across the United States.

Seeking Alpha
Neutral
Chembio Diagnostics, Inc. (CEMI) CEO Richard Eberly on Q2 2021 Results - Earnings Call Transcript
2021-08-07 17:02

Chembio Diagnostics, Inc. (CEMI) CEO Richard Eberly on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Implied Volatility Surging for Chembio Diagnostics (CEMI) Stock Options
2021-08-06 12:16

Investors need to pay close attention to Chembio Diagnostics (CEMI) stock based on the movements in the options market lately.

Benzinga
Negative
Chembio Diagnostics Stock Falls As Q2 Earnings Lag Consensus, Doubt On Ability To Continue As Going Concern
2021-08-06 09:43

Chembio Diagnostics Inc's (NASDAQ: CEMI) Q2 sales increased 26% Y/Y to $6.5 million, missing the consensus of $8.5 million. Net product sales increased 4% to $3.9 million.

Pulse2
Negative
CEMI Stock Price Falls Over 10% Pre-Market: Why It Happened
2021-08-06 04:54

The stock price of Chembio Diagnostics Inc (NASDAQ: CEMI) fell over 10% pre-market. This is why it happened.

Loading more news...